Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 8.01, 9.01 · 8-K

EBR Systems, Inc.

EBRCZOTCEQUITYCurrent

Other Events

Item 8.01 Other Events. On April 14, 2025, EBR Systems, Inc. (the “Company”) issued a press release announcing that the Centers for Medicare & Medicaid Services (CMS) has proposed approval of the New Technology Add-On Payment (NTAP) for EBR’s WiSE CRT System. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.…

Filed Apr 15, 2025Accepted Apr 15, 2025, 5:11 PM EDTCIK 1347123Accession 0001214659-25-005919
Share

Company context

Silicon Valley-based EBR Systems (ASX:EBR) is dedicated to superior treatment of cardiac rhythm disease by providing more physiologically effective stimulation through wireless cardiac pacing. The patented proprietary Wireless Stimulation Endocardially (WiSE) technology was developed to eliminate the need for cardiac pacing leads, historically the major source of complications, effectiveness and reliability issues in cardiac rhythm disease management. The initial product is designed to eliminate the need for coronary sinus leads to stimulate the left ventricle in heart failure patients requiring Cardiac Resynchronisation Therapy (CRT). Future products potentially address wireless endocardial stimulation for bradycardia and other non-cardiac indications.

Current securities

Historical securities (1)

Recent company filings

  1. 10-Q filingNov 9, 2026
  2. S-8 filingAug 24, 2026
  3. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Other EventsAug 24, 2026
  4. Submission of Matters to a Vote of Security HoldersAug 20, 2026
  5. 10-Q filingAug 11, 2026

Disclosure sections

Items 8.01, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 8.01Item 8.01 - Other Events
Item 8.01 Other Events. On April 14, 2025, EBR Systems, Inc. (the “Company”) issued a press release announcing that the Centers for Medicare & Medicaid Services (CMS) has proposed approval of the New Technology Add-On Payment (NTAP) for EBR’s WiSE CRT System. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The Company intend to use its website as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. Such disclosures will be included on the Company’s website in the ‘Investor Relations’ sections. Accordingly, investors should monitor such portions of the Company’s website, in addition to following its press releases, filings with the Securities and Exchange Commission and public conference calls and webcasts. Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release dated April 14, 2025. 104 Cover Page Interactive Data (embedded within the Inline XBRL document).
Filed exhibits (1)
EX-99.1 (by filename) ex99_1.htm

EX-99.1 2 ex99_1.htm EXHIBIT 99.1 Exhibit 99.1 ASX ANNOUNCEMENT 15 April 2025 ─────────────────────────────────────── CMS Proposes Approval of NTAP Reimbursement Key Highlights: The Centers for Medicare & Medicaid Services (CMS) is proposing to approve the WiSE® CRT System for the New Technology Add-On Payment (NTAP) for FY 2026 CMS has recommended WiSE receive the maximum add-on payment of 65% of the device cost, which is in addition to the normal MS-DRG payment. In combination, these are intended to fully cover the cost of the WiSE System. ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────── Award of NTAP is subject to the final rule and will be effective from 1 October 2025 and will remain in effect for three years once approved ─────────────────────────────────────────────────────────────────────────────────── This represents a significant milestone in EBR’s commercialisation strategy, moving one step closer to ensuring US reimbursement for Medicare inpatients An application for Transitional Pass-through (TPT) reimbursement to provide reimbursement f…

Open exhibit ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.